Email Us
View Reports

Malaria Vaccines Market

Malaria Vaccines Market Analysis - By Agent, By Vaccines Type, By Channel of Distribution, By Regions and Market Size, Share, Trends & Forecast Analysis to 2026

  • ID : 786863480  |  
  • Published : Feb-2019  |  
  • Region : Global  |  
  • Pages : 210   |  
  • Publisher : Polaris Market Research

Malaria Vaccines Market Size and Growth Rate:

The malaria vaccines market is expected to reach USD 156.8 million by 2026 according to a new study published by Research Cosmos. The market for malaria vaccines globally has been divided based on vaccine type, agent, channel of distribution and region. Considering the vaccine type, the market is bifurcated into pre-erythrocytic vaccine, erythrocytic vaccine, and multi-antigen vaccine. The channel of distribution used for malaria vaccines include the hospitals, clinics and community centers. Considering the agent used in the malaria vaccines, the global market is divided into plasmodium falciparum, anopheles species, and plasmodium vivax.

Geographically, the Asia Pacific region is expected to grow at the fastest rate among all the other regions with Middle-east & Africa and Latin America likely to be the other potential regions for malaria vaccines market. North America and Europe have considerable lower cases of malaria related diseases with regions such as Latin America and MEA monitoring some of the highest deaths of children related to malaria globally.

Malaria Vaccines Market Growth Drivers:

A few key factors boosting the malaria vaccines market are the growing incidences of malaria along with the presence of numerous companies that are introducing low profit margin vaccines across the world. Moreover, rising awareness related to the aftermaths of the disease, together with growing diagnosis and higher treatment rate are a few other driving factors boosting the malaria vaccines market globally. However, it is high price of vaccines, and weaker supply chain or distribution network in the developing countries among others that act as some of the major restraints for the market growth of malaria vaccines globally. It is expected that the ongoing research activities along with alarming death rates by malaria will further provide numerous opportunities for the growth of the malaria vaccines market in the upcoming years.

A few key strategies adopted by companies operating in the malaria vaccines market are new technology and product development, and geographical expansion among the developing regions to focus on proving vaccines to the areas highly affected by the disease at lower cost. World Health Organization (WHO), in 2015, around 292,000 children died of malaria, at the young age of 5 years in Africa. There were around 306,000 fatalities associated with malaria that was reported worldwide in 2015, out of which around 90% cases were found in Africa. This scenario shows the rising need for empathy towards the disease as well as higher demand for low cost vaccinations.

Major Key Players are mentioned in Malaria Vaccines Market Report:

  • GlaxoSmithKline
  • GenVec, Inc
  • Nobelpharma
  • Sanaria
  • Cadila Healthcare Ltd
  • CellFree Sciences Co. Ltd
  • VLP Therapeutics LLC
  • Genome ReS Ltd

Malaria Vaccines Market – Detailed Segmentation:

Malaria Vaccines Market – By Agent:

  • Plasmodium Falciparum
  • Plasmodium Vivax
  • Anopheles Species

Malaria Vaccines Market – By Vaccines Type:

  • Pre-Erythrocytic Vaccine
  • Erythrocytic Vaccine
  • Multi-antigen Vaccine

Malaria Vaccines Market – By Channel of Distribution:

  • Hospitals
  • Clinics
  • Community Centers

Malaria Vaccines Market By Regions:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Table of Contents:-

1.        Overview and Scope

1.1.        Research goal & scope

1.2.        Research assumptions

1.3.        Research Methodology

1.3.1.        Primary data sources

1.3.2.        Secondary data sources

1.4.        Key take-away

1.5.        Stakeholders

2.        Executive Summary

2.1.        Market Definition

2.2.        Market Segmentation

3.        Malaria Vaccines Market Insights

3.1.        Malaria Vaccines– Industry snapshot

3.2.        Malaria Vaccines-Ecosystem analysis

3.3.        Malaria Vaccines market dynamics

3.3.1.        Malaria Vaccines– Market Forces

3.3.1.1.        Malaria Vaccines Market driver analysis

3.3.1.2.        Malaria Vaccines Market restraint/challenges analysis

3.3.1.3.        Malaria Vaccines Market opportunity analysis

3.4.        Industry analysis - Porter's five force

3.4.1.        Bargaining power of supplier

3.4.2.        Bargaining power of buyer

3.4.3.        Threat of substitute

3.4.4.        Threat of new entrant

3.4.5.        Degree of competition

3.5.        Malaria Vaccines market PEST analysis, 2017

3.6.        Malaria Vaccines market Value Chain analysis

3.7.        Malaria Vaccines Industry trends

3.8.        Competitive Ranking Analysis

4.        Malaria Vaccines Market Size and Forecast by Agent

4.1.        Key Findings

4.2.        Plasmodium Falciparum

4.2.1.        Global Market Estimates and Forecasts, 2017-2026

4.3.        Plasmodium Vivax

4.3.1.        Global Market Estimates and Forecasts, 2017-2026

4.4.        Anopheles Species

4.4.1.        Global Market Estimates and Forecasts, 2017-2026

5.        Malaria Vaccines Market Size and Forecast by Vaccines Type

5.1.        Key Findings

5.2.        Pre-Erythrocytic Vaccine

5.2.1.        Global Market Estimates and Forecasts, 2017-2026

5.3.        Erythrocytic Vaccine

5.3.1.        Global Market Estimates and Forecasts, 2017-2026

5.4.        Multi-antigen Vaccine

5.4.1.        Global Market Estimates and Forecasts, 2017-2026

6.        Malaria Vaccines Market Size and Forecast by Channel of Distribution

6.1.        Key Findings

6.2.        Hospitals

6.2.1.        Global Market Estimates and Forecasts, 2017-2026

6.3.        Clinics

6.3.1.        Global Market Estimates and Forecasts, 2017-2026

6.4.        Community Centers

6.4.1.        Global Market Estimates and Forecasts, 2017-2026

7.        Malaria Vaccines Market Size and Forecast by Regions

7.1.        Key findings

7.2.        North America

7.2.1.        Malaria Vaccines market by Agent, 2017 - 2026

7.2.2.        Malaria Vaccines market by Vaccines Type, 2017 - 2026

7.2.3.        Malaria Vaccines market by Channel of Distribution, 2017 - 2026

7.3.        US.

7.3.1.        Malaria Vaccines market by Agent, 2017 - 2026

7.3.2.        Malaria Vaccines market by Vaccines Type, 2017 - 2026

7.3.3.        Malaria Vaccines market by Channel of Distribution, 2017 - 2026

7.4.        Canada

7.4.1.        Malaria Vaccines market by Agent, 2017 - 2026

7.4.2.        Malaria Vaccines market by Vaccines Type, 2017 - 2026

7.4.3.        Malaria Vaccines market by Channel of Distribution, 2017 - 2026

7.5.        Europe

7.5.1.        Malaria Vaccines market by Agent, 2017 - 2026

7.5.2.        Malaria Vaccines market by Vaccines Type, 2017 - 2026

7.5.3.        Malaria Vaccines market by Channel of Distribution, 2017 - 2026

7.6.        Germany

7.6.1.        Malaria Vaccines market by Agent, 2017 - 2026

7.6.2.        Malaria Vaccines market by Vaccines Type, 2017 - 2026

7.6.3.        Malaria Vaccines market by Channel of Distribution, 2017 - 2026

7.7.        UK

7.7.1.        Malaria Vaccines market by Agent, 2017 - 2026

7.7.2.        Malaria Vaccines market by Vaccines Type, 2017 - 2026

7.7.3.        Malaria Vaccines market by Channel of Distribution, 2017 - 2026

7.8.        France

7.8.1.        Malaria Vaccines market by Agent, 2017 - 2026

7.8.2.        Malaria Vaccines market by Vaccines Type, 2017 - 2026

7.8.3.        Malaria Vaccines market by Channel of Distribution, 2017 - 2026

7.9.        Asia Pacific

7.9.1.        Malaria Vaccines market by Agent, 2017 - 2026

7.9.2.        Malaria Vaccines market by Vaccines Type, 2017 - 2026

7.9.3.        Malaria Vaccines market by Channel of Distribution, 2017 - 2026

7.10.        China

7.10.1.        Malaria Vaccines market by Agent, 2017 - 2026

7.10.2.        Malaria Vaccines market by Vaccines Type, 2017 - 2026

7.10.3.        Malaria Vaccines market by Channel of Distribution, 2017 - 2026

7.11.        India

7.11.1.        Malaria Vaccines market by Agent, 2017 - 2026

7.11.2.        Malaria Vaccines market by Vaccines Type, 2017 - 2026

7.11.3.        Malaria Vaccines market by Channel of Distribution, 2017 - 2026

7.12.        Japan

7.12.1.        Malaria Vaccines market by Agent, 2017 - 2026

7.12.2.        Malaria Vaccines market by Vaccines Type, 2017 - 2026

7.12.3.        Malaria Vaccines market by Channel of Distribution, 2017 - 2026

7.13.        Latin America

7.13.1.        Malaria Vaccines market by Agent, 2017 - 2026

7.13.2.        Malaria Vaccines market by Vaccines Type, 2017 - 2026

7.13.3.        Malaria Vaccines market by Channel of Distribution, 2017 - 2026

7.14.        Brazil

7.14.1.        Malaria Vaccines market by Agent, 2017 - 2026

7.14.2.        Malaria Vaccines market by Vaccines Type, 2017 - 2026

7.14.3.        Malaria Vaccines market by Channel of Distribution, 2017 - 2026

7.15.        Mexico

7.15.1.        Malaria Vaccines market by Agent, 2017 - 2026

7.15.2.        Malaria Vaccines market by Vaccines Type, 2017 - 2026

7.15.3.        Malaria Vaccines market by Channel of Distribution, 2017 - 2026

7.16.        Middle East & Africa

7.16.1.        Malaria Vaccines market by Agent, 2017 - 2026

7.16.2.        Malaria Vaccines market by Vaccines Type, 2017 - 2026

7.16.3.        Malaria Vaccines market by Channel of Distribution, 2017 - 2026

7.17.        Company Profiles

7.18.        GlaxoSmithKline

7.18.1.        Overview

7.18.2.        Financials

7.18.3.        Product Benchmarking

7.18.4.        Recent Developments

7.19.        GenVec, Inc.

7.19.1.        Overview

7.19.2.        Financials

7.19.3.        Product Benchmarking

7.19.4.        Recent Developments

7.20.        Nobelpharma

7.20.1.        Overview

7.20.2.        Financials

7.20.3.        Product Benchmarking

7.20.4.        Recent Developments

7.21.        Sanaria

7.21.1.        Overview

7.21.2.        Financials

7.21.3.        Product Benchmarking

7.21.4.        Recent Developments

7.22.        Cadila Healthcare Ltd.

7.22.1.        Overview

7.22.2.        Financials

7.22.3.        Product Benchmarking

7.22.4.        Recent Developments

7.23.        VLP Therapeutics LLC

7.23.1.        Overview

7.23.2.        Financials

7.23.3.        Product Benchmarking

7.23.4.        Recent Developments

7.24.        CellFree Sciences Co. Ltd.

7.24.1.        Overview

7.24.2.        Financials

7.24.3.        Product Benchmarking

7.24.4.        Recent Developments

7.25.        Genome ReS Ltd.

7.25.1.        Overview

7.25.2.        Financials

7.25.3.        Product Benchmarking

7.25.4.        Recent Developments

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?